NCT00206622 - Efficacy and Safety Study in Postmenopausal Women to Determine the Lowest Effective Dose for Relief of Moderate to Severe Hot-Flushes | Biotech Hunter

Enrollment

425

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

February 28, 2006

Conditions

Hot Flashes

Interventions

DRUG

Climara PRO (Estradiol / Levonorgestrel transdermal)

2.2mg 17 Beta-estradiol/0.69mg levonorgestrel combination transdermal patch

DRUG

Menostar (Estradiol transdermal)

1mg 17 Beta-estradiol transdermal patch

DRUG

Placebo transdermal

Placebo

Trial Locations (45)

15206

Pittsburgh

19114

Philadelphia

27103

Winston-Salem

30005

Alpharetta

32216

Jacksonville

33409

West Palm Beach

33613

Tampa

33916

Fort Myers

35801

Huntsville

38120

Memphis

40536

Lexington

43213

Columbus

44122

Cleveland

45236

Cincinnati

46601

South Bend

48201

Detroit

60612

Chicago

61615

Peoria

61820

Champaign

63110

St Louis

68510

Lincoln

70115

New Orleans

76012

Arlington

77004

Houston

77030

Houston

83404

Idaho Falls

83702

Boise

84124

Salt Lake City

85031

Phoenix

85225

Chandler

85712

Tucson

87102

Albuquerque

89502

Reno

92103

San Diego

92108

San Diego

92123

San Diego

94612

Oakland

95628

Fair Oaks

06050

New Britain

06117

West Hartford

32610-0254

Gainesville

70118-1034

New Orleans

08901

New Brunswick

76502-1896

Temple

05401-1420

Burlington